BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36327610)

  • 21. Production of the PET radionuclide
    Brühlmann SA; Walther M; Kopka K; Kreller M
    EJNMMI Radiopharm Chem; 2024 Jan; 9(1):3. PubMed ID: 38180574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of copper radionuclides and production of 61Cu by proton irradiation of (nat)Zn at a medical cyclotron.
    Rowshanfarzad P; Sabet M; Jalilian AR; Kamalidehghan M
    Appl Radiat Isot; 2006 Dec; 64(12):1563-73. PubMed ID: 16377202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactor produced [
    Chakravarty R; Shetty P; Nair KVV; Rajeswari A; Jagadeesan KC; Sarma HD; Rangarajan V; Krishnatry R; Chakraborty S
    Ann Nucl Med; 2020 Dec; 34(12):899-910. PubMed ID: 33048309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotensin (8-13) and Neuromedin N Neuropeptides Radiolabelling with Copper-64 Produced on Solid or Liquid Targets.
    Cocioabă D; Fonseca AI; Leonte R; Hrynchak I; Tudoroiu-Cornoiu R; do Carmo SJC; Burghelea B; Băruță S; Almeida AR; Șerban R; Dinischiotu A; Abrunhosa AJ; Niculae D
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38543026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interdisciplinary Tasks in the Cyclotron Production of Radiometals for Medical Applications. The Case of
    Boschi A; Martini P; Costa V; Pagnoni A; Uccelli L
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30691170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in copper radiopharmaceuticals.
    Hao G; Singh AN; Oz OK; Sun X
    Curr Radiopharm; 2011 Apr; 4(2):109-21. PubMed ID: 22191650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Evaluation of Copper Radioisotope Production at ISOLPHARM.
    Borgna F; Ballan M; Favaretto C; Verona M; Tosato M; Caeran M; Corradetti S; Andrighetto A; Di Marco V; Marzaro G; Realdon N
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30249975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient production of high specific activity 64Cu using a biomedical cyclotron.
    McCarthy DW; Shefer RE; Klinkowstein RE; Bass LA; Margeneau WH; Cutler CS; Anderson CJ; Welch MJ
    Nucl Med Biol; 1997 Jan; 24(1):35-43. PubMed ID: 9080473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taking cyclotron
    Nelson BJB; Wilson J; Richter S; Duke MJM; Wuest M; Wuest F
    Nucl Med Biol; 2020; 80-81():24-31. PubMed ID: 32004935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel approach to medical radioisotope production using inverse kinematics: A successful production test of the theranostic radionuclide
    Souliotis GA; Rodrigues MRD; Wang K; Iacob VE; Nica N; Roeder B; Tabacaru G; Yu M; Zanotti-Fregonara P; Bonasera A
    Appl Radiat Isot; 2019 Jul; 149():89-95. PubMed ID: 31035108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New method for production of
    Moiseeva AN; Aliev RA; Furkina EB; Novikov VI; Unezhev VN
    Nucl Med Biol; 2022; 106-107():52-61. PubMed ID: 35032789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of production cross-sections for theranostic
    Ali SKI; Khandaker MU; Al-Mugren KS; Latif SA; Bradley DA; Okhunov AA; Sulieman A
    Appl Radiat Isot; 2021 Jul; 173():109735. PubMed ID: 33915407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous production of high specific activity 64Cu and 61Co with 11.4 MeV protons on enriched 64Ni nuclei.
    Avila-Rodriguez MA; Nye JA; Nickles RJ
    Appl Radiat Isot; 2007 Oct; 65(10):1115-20. PubMed ID: 17669663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target Approach.
    Hrynchak I; Cocioabă D; Fonseca AI; Leonte R; do Carmo SJC; Cornoiu R; Falcão A; Niculae D; Abrunhosa AJ
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small-scale production of
    Ohya T; Nagatsu K; Suzuki H; Fukada M; Minegishi K; Hanyu M; Zhang MR
    Nucl Med Biol; 2018 Apr; 59():56-60. PubMed ID: 29475187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy.
    Nelson BJB; Andersson JD; Wuest F
    Nucl Med Biol; 2022; 110-111():59-66. PubMed ID: 35487834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
    Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
    Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IAEA Activities on
    Jalilian AR; Gizawy MA; Alliot C; Takacs S; Chakarborty S; Rovais MRA; Pupillo G; Nagatsu K; Park JH; Khandaker MU; Mikolajczak R; Bilewicz A; Okarvi S; Gagnon K; Al Rayyes AH; Lapi SE; Starovoitova V; Korde A; Osso JA
    Curr Radiopharm; 2021; 14(4):306-314. PubMed ID: 32988359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theragnostic
    Lee JY; Chae JH; Hur MG; Yang SD; Kong YB; Lee J; Ju JS; Choi PS; Park JH
    Front Med (Lausanne); 2022; 9():889640. PubMed ID: 35665337
    [No Abstract]   [Full Text] [Related]  

  • 40. Study of terbium production from enriched Gd targets via the reaction
    Wang Y; Sounalet T; Guertin A; Nigron E; Michel N; Haddad F
    Appl Radiat Isot; 2023 Nov; 201():110996. PubMed ID: 37657224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.